Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: GENEIMMUNE BIOTECHNOLOGY CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-13 to 2023-04-06
Current total value of award: $98347.4
Description: GENEIMMUNE BIOTECHNOLOGY LLC_DNA SERVICES